ArticleCureus2026
Seronegative Longitudinally Extensive Transverse Myelitis in a Filipino Adult: Diagnostic Challenges and Characteristic Longitudinal MRI Findings.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Longitudinally extensive transverse myelitis (LETM) is a radiologic pattern of longitudinal spinal cord involvement most commonly associated with antibody-mediated autoimmune diseases such as neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease. Seronegative inflammatory cases remain diagnostically challenging because they require careful exclusion of infectious, autoimmune, vascular, neoplastic, metabolic, and structural etiologies. A 45-year-old Filipino female presented with a three-day history of severe upper back pain, followed by rapidly progressive bilateral upper and lower extremity weakness, sensory disturbances, and urinary retention. Neurologic examination revealed asymmetric quadriparesis, a sensory level at the fourth thoracic dermatome, preserved vibration and proprioception, and mixed hyperreflexia and hyporeflexia with bilateral Babinski signs. Spinal magnetic resonance imaging (MRI) demonstrated a poorly defined, non-expansile intramedullary T2-hyperintense lesion extending contiguously from C3 to T2 without discrete enhancement. Diffusion-weighted imaging demonstrated no restricted diffusion. Cerebrospinal fluid analysis showed mild lymphocytic pleocytosis with normal IgG index and absence of oligoclonal bands. Extensive infectious, inflammatory, autoimmune, and metabolic investigations were unrevealing, including negative serum aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies. Follow-up spinal MRI performed 3.5 months later demonstrated persistent longitudinal non-enhancing intramedullary T2 hyperintensity with evolution toward chronic myelomalacic change, providing important longitudinal imaging evidence supporting an inflammatory antibody-negative myelopathy over competing diagnostic considerations. The patient was treated with high-dose intravenous methylprednisolone, followed by an oral prednisone taper and subsequent initiation of azathioprine because of persistent severe deficits. Despite immunotherapy and rehabilitation, she remained wheelchair-dependent with persistent dysesthesias and neurogenic bladder at follow-up. Following comprehensive multidisciplinary evaluation and longitudinal follow-up, an inflammatory antibody-negative LETM was considered the most likely diagnosis after exclusion of competing etiologies. This case highlights the diagnostic complexity, therapeutic challenges, and potentially severe neurologic outcomes associated with seronegative LETM. It also underscores the importance of systematic exclusion of alternative etiologies, longitudinal follow-up, repeat serologic evaluation, and individualized consideration of escalation immunotherapy in patients with incomplete response to corticosteroid treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.